Owner Orion Genomics, LLC

Convention US 18 October 2010 85155102

Service Refer to WIPO Address for Correspondence

Filing Date 17 April 2011

Class 5 Medical diagnostic test kits comprised of enzymes, nucleic acids, and chemicals for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in genomics, pharmacogenomics, life sciences, pharmaceuticals, the diagnosis of disease, such as cancer, metabolic disorders, psychiatric disorders, age-related disorders central nervous system and infectious diseases; agriculture diagnostic test kits comprised of enzymes, nucleic acids, and chemicals for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in biotechnology and breeding; veterinary diagnostic test kit comprised of enzymes, nucleic acids, and chemicals for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in biotechnology, genomics, and breeding; microbiological diagnostic test kit for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in biotechnology, genomics, homeland security, and biodefense

Class 44 Diagnostic services, namely, diagnosis of disease, such as cancer, metabolic disorders, psychiatric disorders, age-related disorders, central nervous system disorders and infectious disease in animals, including humans; diagnostic services, namely, the diagnosis of infection, the detection of microbes, and the identification of viral, bacterial, fungal or other pathogens to identify the presence, subtype, the method of manufacture and evidence of infection or disease